Dynavax is a commercial stage biopharmaceutical company built on the foundation of our significant experience and expertise in vaccine development and commercialization. Our mission is to develop and commercialize new or improved vaccines utilizing proven, innovative adjuvant technology to help protect the world against infectious diseases.
